Skip to main content

Table 2 Homology model quality validation scores of partial zymogen complexes using different assessment tools

From: Comparing sequence and structure of falcipains and human homologs at prodomain and catalytic active site for malarial peptide based inhibitor design

Protein Z-DOPE Verify3D ProSA QMEAN RAMACHANDRAN (%)
Favoured Allowed Disallowed
FP-2 − 1.05 78.48 − 8.27 0.69 88.90 10.50 0.60
FP-3 − 0.94 84.64 − 7.84 0.67 89.70 10.30 0.00
VP-2 − 0.64 81.27 − 6.94 0.62 85.40 13.90 0.70
VP-3 − 0.74 79.58 − 7.31 0.70 88.60 11.40 0.00
KP-2 − 0.63 85.89 − 7.23 0.62 89.30 9.70 1.00
KP-3 − 0.92 90.63 − 7.88 0.63 86.10 13.90 0.00
BP-2 − 0.62 86.85 − 7.75 0.63 86.60 12.40 1.00
CP-2 − 0.60 84.45 − 7.02 0.63 83.90 13.80 2.30
YP-2 − 0.42 75.54 − 7.28 0.62 84.90 14.40 0.70
Cat-L − 1.47 87.38 − 7.94 0.87 89.80 9.80 0.40
Cat-S − 1.61 85.39 − 8.57 0.79 89.20 10.40 0.20
1BY8 * 85.16 − 8.62 0.78 65.80 34.20 0.00
2O6X * 94.77 − 7.00 0.77 90.50 9.50 0.00
2OUL * 98.13 − 7.90 0.75 88.10 11.20 0.70
3BWK * 93.51 − 7.35 0.65 86.10 13.30 0.60
  1. * Template
\